Skip to content

Clinical trials

Atrial Fibrillation trials in Hong Kong with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Not applicable Country / region: Hong Kong Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20151
20171
20182
20191
20203
20211
20233
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation5
Chinese University of Hong Kong4
Abbott Medical Devices3
The University of Hong Kong2
Prince of Wales Hospital, Shatin, Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation15
Stroke2
Cardiovascular Diseases1
Gastrointestinal Hemorrhage1
Heart Diseases1
Hemorrhage1
Sick Sinus Syndrome1
Thromboembolism1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.